Company intelligence / Profile preview

Civilization Ventures

San Francisco, California, United Statescivilizationventures.com ↗

Ownership: Private
Development stage: Other

Overview

Civilization Ventures does not conduct clinical trials itself but has invested in multiple category-defining life science and digital health startups. Its portfolio includes several successful exits such as Rocket Pharma’s IPO and acquisitions of Singular Bio by Invitae and Rewrite Therapeutics by Intellia[1][5].

Therapeutic areas: OncologyRare DiseasesOther
Modalities: Gene therapyCell therapyDigital health platformsArtificial intelligence-based diagnostics
Industry: Investors

Beyond the preview

Go deeper on Civilization Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Civilization Ventures.

Explore the full profile